COMMUNIQUÉS West-GlobeNewswire

GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Quarter Ended December 31, 2018
26/02/2019
– Epidiolex ® (cannabidiol) oral solution (CV), first FDA-approved plant-derived cannabinoid medicine, launched in the U.S. in November to high awareness and demand – – GW moves to a new fiscal year-end beginning [...]
Merit Medical Reports Earnings for Fourth Quarter and Year Ended December 31, 2018, Gives 2019 and 2020 Guidance
26/02/2019
Q4 2018 worldwide revenue of $233.2 million, up 22.2% as reported over Q4 2017 Q4 2018 core revenue on a comparable, constant currency basis* up 13.1% over Q4 2017 Q4 2018 GAAP EPS was $0.16, compared to $0.13 in Q4 [...]
Retrophin Reports Fourth Quarter and Full Year 2018 Financial Results
26/02/2019
Top-line results from pivotal Phase 3 FORT Study in PKAN expected in 3Q 2019 Two pivotal Phase 3 studies of sparsentan progressing on-track to enable potential first-in-class treatment for both FSGS and IgAN SAN DIEGO, [...]
MacroGenics Provides Update on Corporate Progress and 2018 Financial Results
26/02/2019
Margetuximab: Positive Phase 3 SOPHIA study with BLA submission planned for second half of 2019; Plans to initiate Phase 2/3 registration-directed, front-line gastric cancer study Enoblituzumab: Encouraging anti-PD-1 [...]
Dermira Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
26/02/2019
QBREXZA™ (glycopyrronium) cloth 2018 net product sales of $3.0 million Over 14,500 prescriptions for QBREXZA written in first three months of launch Secured QBREXZA coverage for approximately 76% of total U.S. [...]
Axogen, Inc. Reports 2018 Fourth Quarter and Full Year 2018 Financial Results
26/02/2019
Fourth Quarter Revenue of $23.4 million, representing 38% growth over prior year Full Year 2018 Revenue of $83.9 million, representing 39% growth over prior year ALACHUA, Fla., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Axogen, [...]
Alder BioPharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
26/02/2019
BOTHELL, Wash., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, announced [...]
VitalHub Corp. Announces Agreement to Acquire the Assets of the Oak Group, Inc.
26/02/2019
TORONTO, Feb. 26, 2019 (GLOBE NEWSWIRE) -- VITALHUB CORP. (TSXV: VHI) (the “Company” or “VitalHub”), is pleased to announce that today it has entered into an arm’s length agreement (the “Agreement”) to acquire [...]
Chiesi USA, Inc. Moves to New Headquarters in Regency Woods II
26/02/2019
The company combines its Cary-based employees under one roof in two floors of communal space CARY, N.C., Feb. 26, 2019 (GLOBE NEWSWIRE) -- This week, approximately 135 employees of Chiesi USA, Inc. (key-A-zee) , a Cary- [...]
Atrion Corporation Declares Quarterly Cash Dividend
26/02/2019
ALLEN, Texas, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that its Board of Directors declared a quarterly dividend of $1.35 per share on its outstanding shares of Common Stock. [...]
Forced Vaccination Unnecessary, Violates Human Rights, States Association of American Physicians and Surgeons (AAPS)
26/02/2019
TUCSON, Ariz., Feb. 26, 2019 (GLOBE NEWSWIRE) -- An outbreak of measles in Washington State is the latest news hook for efforts to tighten vaccine mandates and oppose efforts, as in Arizona, to strengthen protections [...]
Myriad’s BRACAnalysis CDx® Test Successfully Identified Patients with Metastatic Pancreatic Cancer Who Benefitted from Treatment with Olaparib
26/02/2019
Myriad Will Seek FDA Approval of BRACAnalysis CDx as a Companion Diagnostic for Olaparib in this Patient Population SALT LAKE CITY, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ: MYGN), a leader in [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
26/02/2019
Company Announcement Copenhagen, Denmark; February 26, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 26,297 shares as a consequence of the exercise of employee warrants. The increase is [...]
Hinds Hospice Partners with Elemeno Health to Provide Superior Patient Care
26/02/2019
Hinds first Hospice Organization to Implement Cloud-based Solution Enabling Caregivers to Improve Quality of Service and Patient Experience OAKLAND, Calif. and FRESNO, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Elemeno [...]
GW Pharmaceuticals to Present at Upcoming Investor Conferences
26/02/2019
- Leerink Partners 8 th Annual Global Healthcare Conference on February 28, 2019 - - Cowen and Company 39 th Annual Health Care Conference on March 11, 2019 - LONDON and CARLSBAD, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE [...]
Tauriga Sciences Inc. Completes Production of Initial Inventory Tranche of its CBD Infused Chewing Gum
26/02/2019
New York, NY, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]
Innovation Pharmaceuticals Forms Irish Subsidiary to Facilitate International Development of Clinical Pipeline
26/02/2019
BEVERLY, Mass., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to announce that the Companies Registration Office [...]
Cutera Announces Global Commercial Launch Of the excel V+® the Next Generation Laser Platform
26/02/2019
Developed in Collaboration with Leading Dermatologists, For Indications in Vascular, Skin and Pigmentation Treatments WASHINGTON, Feb. 26, 2019 (GLOBE NEWSWIRE) -- On the eve of the 2019 American Academy of Dermatology [...]
Medtronic Resolute(TM) Drug-Eluting Stent (DES) Platform Receives Expanded Indication for Treatment of Chronic Total Occlusion (CTO)
26/02/2019
FDA Approval Allows Interventional Cardiologists Access to Resolute DES Technology to Treat De Novo CTO DUBLIN - February 26, 2019 - Medtronic plc (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) [...]

Pages